Optimal dilutions for each application to be determined by the researcher.
Anwendungsbeschreibung:
Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.
Immobilized 2019-nCoV S Protein RBD-SD1-mFc at 5µg/ml (100 µl/well) can bind Anti-2019-nCoV S1 mAb (5D9) (Cat93-311). The ED50 of Anti-2019-nCoV S1 mAb (5D9) is 24.5 ng/ml.
Immobilized 2019-nCoV S1 Protein-His at 2µg/ml (100 µl/well) can bind Anti-2019-nCoV S1 mAb (5D9) (Cat93-311).The ED50 of Anti-2019-nCoV S1 mAb (5D9) (Cat93-311) is 36.9 ng/ml.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten